Clinical Trial Update: Effect of Local Anesthetic EMLA (Lidocaine 2.5% and Prilocaine 2.5%) Cream and Reduction in Dose, Pain and Intravenous Analgesic During Permanent Pacemaker Implantation [NA]

View source ↗

Summary

The trial update evaluates the use of EMLA cream (lidocaine 2.5% and prilocaine 2.5%) to reduce local anesthetic dose, pain, and the need for intravenous analge…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrioventricular Block
• Bradycardia

Drugs mentioned

• EMLA Cream (lidocaine 2.5% / prilocaine 2.5% topical cream)

Snippet

Sponsor: Hillel Yaffe Medical Center | Conditions: Pacemaker Implantation, Pain | NA | Status: UNKNOWN